This NDC is on FDA's drug shortage list (posted Jul 18, 2023)

Product Information

LIRAGLUTIDE 2-PAK 18 MG/3 ML is a generic product labeled by Meitheal Pharmaceuticals Inc., priced at $25.6669 per ML under NDC 71288056385. Its NADAC has been published 76 times since Jun 11, 2025.

FDA first approved this application on Apr 2, 2025. Its Orange Book therapeutic-equivalence code is AP1.

LIRAGLUTIDE 2-PAK 18 MG/3 ML

liraglutide
$25.6669per ML

Strength

6 mg/mL

NDC

71288056385

Classification

Generic

Dosage Form

INJECTION

Route

SUBCUTANEOUS

Effective Date

11/18/2026

Active Ingredients

LIRAGLUTIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA218115

FDA Approved

4/2/2025

TE Code

AP1

On Market Since

4/2/2025

Pharmacological Classes

GLP-1 Receptor Agonist
Glucagon-Like Peptide 1
Glucagon-like Peptide-1 (GLP-1) Agonists

Price Statistics

The NADAC for LIRAGLUTIDE 2-PAK 18 MG/3 ML has been published 76 times since Jun 11, 2025, and over the history we have for it it has declined 60.8%. The table below summarizes its recorded NADAC range and movement.

Current price$25.6669 per ML
All-time high$65.6636 (Sep 10, 2025)
All-time low$25.6669 (Nov 18, 2026)
52-week high$54.7952
52-week low$25.6669
Median price$48.7442
Average price$48.0005
Largest weekly change-11.1% (Apr 22, 2026)
Weeks tracked76
Tracking sinceJun 11, 2025

Price History

1W

-10.2%

1M

-18.3%

3M

-24.1%

6M

-33.5%

1Y

-55.6%

3Y

N/A

5Y

N/A

All

-60.8%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LIRAGLUTIDE 2-PAK 18 MG/3 ML?

The current National Average Drug Acquisition Cost (NADAC) for LIRAGLUTIDE 2-PAK 18 MG/3 ML, manufactured by Meitheal Pharmaceuticals Inc., is $25.6669 per ML (NDC 71288056385), effective Nov 18, 2026.

How has the price of LIRAGLUTIDE 2-PAK 18 MG/3 ML changed over time?

Over the history we have for it, the NADAC for LIRAGLUTIDE 2-PAK 18 MG/3 ML has declined 60.8%. It has been tracked across 76 weekly CMS publications since Jun 11, 2025.

What are the highest and lowest recorded NADAC prices for LIRAGLUTIDE 2-PAK 18 MG/3 ML?

Since Jun 11, 2025, the NADAC for LIRAGLUTIDE 2-PAK 18 MG/3 ML has ranged from a low of $25.6669 (Nov 18, 2026) to a high of $65.6636 (Sep 10, 2025), with a median of $48.7442 per ML.

Are there cheaper alternatives to LIRAGLUTIDE 2-PAK 18 MG/3 ML?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LIRAGLUTIDE 3-PAK 18 MG/3 ML, is $25.4444 per ML — about 1% below LIRAGLUTIDE 2-PAK 18 MG/3 ML.

Who manufactures LIRAGLUTIDE 2-PAK 18 MG/3 ML?

LIRAGLUTIDE 2-PAK 18 MG/3 ML (NDC 71288056385) is labeled by Meitheal Pharmaceuticals Inc., and CMS classifies it as a generic product.

Is LIRAGLUTIDE 2-PAK 18 MG/3 ML in shortage?

Yes — NDC 71288056385 is currently listed in FDA's drug shortage database (posted Jul 18, 2023).